Anticonvulsant and neuronal protective effects of propofol on experimental status epilepticus

Journal of Epilepsy

Volumn 11, Issue 3, 1998, Pages 168-176

  Ahuja, Shalini ^a   Germano, Isabelle M ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Glial fibrillary acidic protein; Hippocampus; Neuronal damage; Propofol; Seizures; Status epilepticus

Indexed keywords

ANTICONVULSIVE AGENT; GLIAL FIBRILLARY ACIDIC PROTEIN; KAINIC ACID; NEUROPROTECTIVE AGENT; PROPOFOL; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTICONVULSANT ACTIVITY; ARTICLE; ASTROCYTOSIS; CONTROLLED STUDY; EPILEPTIC STATE; HIPPOCAMPUS; INTRAVENOUS DRUG ADMINISTRATION; LATENT PERIOD; MORTALITY; NERVE CELL LESION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0031834688     PISSN: 08966974     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0896-6974(98)00008-5     Document Type: Article

References (48)

1. Treiman DM. Generalized convulsive status epilepticus in the adult. Epilepsia. 34:(Suppl. 1):1993;s2-s11.
2. Cascino GD. Generalized convulsive status epilepticus. Mayo Clinic Proc. 71:1996;787-792.
3. Aminoff MF, Simon RP. Status epilepticus Causes, clinical features and consequences in 98 patients . Am J Med. 69:1980;657-666.
4. Wasterlaine CG, Fujikawa DG, Penix L, Sankar R. Pathophysiology mechanisms of brain damage from status epilepticus. Epilepsia. 34:(Suppl. 1):1993;S37-S53.
5. Van Esch A, Ramlal IR, Van Steensel Moll HA, Steyerberg EW, Derksen Lubsen G. Outcome after febrile status epilepticus. Dev Med Child Neurol. 38:1996;19-24.
6. Merigian KS, Browning RG, Leeper KV. Sucessful treatment of amoxapine-induced status-epilepticus with propofol (diprivan). Acad Emerg Med. 2:1995;128-133.
7. Harden CL. Views and reviews New antiepileptic drugs . Neurology. 44:1994;787-795.
8. Kuisma M, Roine RO. Propofol in prehospital treatment of convulsive status epilepticus. Epilepsia. 36:1995;1241-1243.
9. Alia EN, Mattaliano A, Daniele O. On two cases of status epilepticus treated with propofol. Epilepsia. 32:1991;77.
10. Campostrini R, Bati MB, Giorgi C, Palumbo P, Serra P, Vinattieri A, Cantini A, Martini E. Propofol in the treatment fo convulsive status epilepticus A report of four cases . Nuova Rivista Neurologia. 61:1991;176-179.
11. Mc Burney JW, Teiken PJ, Moon MR. Propofol for treating status epilepticus. J Epilepsy. 7:1994;21-22.
12. Wood PR, Browne GP, Pugh S. Propofol infusion for the treatment of status epilepticus (letter). Lancet. 1:1988;480-481.
13. Bansinath M, Shukla VK, Turndoff H. Propofol modulates the effects of chemoconvulsants acting at GABAergic glysinergic and glutamate receptor subtypes. Anesthesiology. 83:1995;809-815.
14. Hasan Z, Hasan M, Al-Hader AF, Takrouri M. A comparison of the anticonvulsant effects of propofol and thiopentane against pentylenetetrazol-induced convulsions in the rat. Clin Exp Pharmacol Physiol. 18:1991;691-695.
15. Hasan ZA, Hasan MM, Al-Hader AF, Takrouri MS. The effects of propofol and thiopentane on pentylenetetrazol seizure threshold in the rat. M E J Anesth. 11:1992;359-367.
16. Al-Hader AF, Hasan M, Hasan Z. The comparative effects of propofol, thiopentale, and diazepam, administered intravenously on pentylenetetrazol seizure threshold in the rabbit. Life Sci. 51:1992;779-786.
17. Lowson S, Gent JP, Goodchild CS. Anticonvulsant properties of propofol and thiopentane comparison using two tests in laboratory mice . Br J Anaesth. 64:1990;59-63.
18. Samra Sk, Snyed JR, Ross DA, Henry TR. Effects of propofol sedation on seizure intracranially recorded epileptiform of patients with partial epilepsy. Anesthesiology. 82:1995;843-851.
19. Au J, Walker WS, Scott DH. Withdrawal syndrome after propofol infusion. Anaesthesia. 45:1990;741-742.
20. Cameron AE. Opisthotonus again [letter]. Anaesthesia. 42:1987;1124.
21. DeFriez CB, Wong HC. Seizures and opistothotonus after propofol anesthesia. Anesth Analg. 75:1992;630-632.
22. Jones GW, Boykett MH, Klok M. Propofol, ophisthotonus and epilepsy [letter]. Anaesthesia. 43:1988;905.
23. Makela JP, Livanainen M, Pieninkeroinen IP, Waltimo O, Lahdensuu M. Seizures associated with propofol anesthesia. Epilepsia. 34:1993;832-835.
24. Albala BJ, Moshe SL, Okada R. Kainic-acid induced seizures A developmental study . Dev Brain Res. 13:1984;139-148.
25. Sternberger LA, Hardy PH, Cuculis JJ, Meyer HG. The unlabelled antibody-enzyme method of immunohistochemistry preparation of soluable antigen-antibody complex (horse-radish peroxidase) and its use in the identification of spirochettes . J Histochem Cytochem. 18:1970;315-333.
26. Delgado-Escueta AY, Wasterlaine C, Treiman DM. Current concepts in neurology Management of status epilepticus . N Engl J Med. 306:1982;1337-1340.
27. Meldrum BS, Brierley JB. Prolonged epileptics seizures in primates Ischemic cell change and its relation to ictal physiological events . Arch Neurol. 28:1973;10-17.
28. Briggs LP, Clarke SJ, Dundee JW, Moore J, Bahar M, Wright PJ. Use of di-isopropyl as main agent for short procedures. Br J Anaesth. 53:1981;1197-1202.
29. O'Toole DP, Milligian KR, Howe JP, McCollum JSC, Dundee JW. A comparison of propofol and methohexitone as induction agents for day case isoflurane anaesthesia. Anaesthesia. 42:1987;373-376.
30. Bone ME, Wilkins CJ, Lew JK. A comparison of propofol and methohexitone as anesthetic agents for electroconvulsive therapy. Eur J Anaesthsiol. 5:1988;279-286.
31. Simpson KH, Halsall PJ, Carr CM, Stewart KG. Propofol reduces seizure duration in patients having anesthesia for electroconvulsive therapy. Br J Anaesth. 61:1988;343-344.
32. Hopkins CS. Recurrent opisthotonus associated with anesthesia. Anesthesia. 43:1988;904.
33. Bevan JC. Propfol-related convulsions. Can J Anesth. 40:1993;805-809.
34. Glen JB, Hunter SB, Blackburn TP, Wood P. Interaction studies and other investigations of the pharmacology of propofol (Diprivan). Postgrad Med J. 65:1985;7-14.
35. Concas A, Santoro G, Mascia MP, Sanna E, Biggio G. The general anesthetic propofol enhances the function of alpha-aminobutyric acid-coupled chloride channel in the rat cerebral cortex. J Neurochem. 55:1990;2135-2138.
36. Peduto VA, Concas A, Santaro G, Biggio G, Gessa GL. Biochemical and electrophysiological evidence that propofol enhances GABAergic transmission in the rat brain. Anesthsiology. 75:1991;1000-1009.
37. Frenkel C, Urban BW. Human brain sodium channels as one of the molecular target sites for the new intravenous anesthetic propofol (2,6 diisopropylphenol). Eur J Pharmacol Mol Pharm Sect. 208:1991;75-79.
38. Mantz J, Cordier J, Giaume C. Effects of general anesthetic on intercellular communications mediated by gap junctions between astrocytes in primary culture. Anesthesiology. 78:1993;892-901.
39. Ramani R, Todd MM, Warner DS. A dose-response study of the influence of propofol on cerebral blood flow, metabolism, and the electrencephelogram in the rabbit. J Neurosurg Anesthesiol. 4:1994;110-119.
40. Kochs E, Hoffman WE, Werner C, Thomas C, Albrecht RF, Schulte J. The effects of propofol on brain electrical activity, neurologic outcome and neuronal damage following incomplete ischemia in rats. Anesthesiology. 76:1992;245-252.
41. Arcardi FA, Rapisarda A, De Luca R, Trimarchi GR, Costa G. Effect of 2,6 diisopropylphenol on the delayed hippocampal cell loss following transient ischemia in the gerbil. Life Sci. 58:1996;961-970.
42. Siesjo BK, Ingvar M, Folbergrova J, Chapman AG. Local cerebral circulation and metabolism in bicuculline-induced status epilepticus: relevance for development of cell damage. In: delgado-Escueta AV, Wasterlain CG, Treiman DM, Porter RJ, eds. Status epilepticus. New York: Raven Press, 1993:217-230. (Advances in neurology; vol. 34).
43. Fujikawa DG. The temporal evolution of neuronal damage from pilocarpine-induced status epilepticus. Brain Res. 725:1996;11-22.
44. Tanaka K, Graham SH, Simon RP. The role of excitatory neurotransmitters in seizure-induced neuronal injury in rats. Brain Res. 737:1996;59-63.
45. Kirino T. Delayed neuronal death in the gerbil hippocampus following ischemia. Brain Res. 239:1982;57-69.
46. Illievich LM, Zornow MH, Choi KT, Strnat MAP, Scheller MS. Effects of hypothermia or anesthetics on hippocampal glutamate and glycine concentrations after repeated transient global cerebral ischemia. Anesthesiology. 80:1994;177-186.
47. Johnson JW, Ascher P. Glycine potentiates the NMDA response in cultured mouse brain neurons. Nature. 325:1987;529-531.
48. Babb TL, Brown WJ, Pretorius J, Davenport C, Lieb JP, Crandall PH. Temporal lobe volumetric cell densisites in temporal lobe. Epilepsia. 29:1984;674-684.